NGM Biopharmaceuticals Inc
NGMDelisted Apr 5, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001426332
NGM Biopharmaceuticals Inc was delisted on Apr 5, 2024; its insiders filed their last Form 4 on Apr 8, 2024; 75 institutions reported holding it in 13F filings for Q1 2024, worth $55.1M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in NGM Biopharmaceuticals Inc as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 121
- +14 vs. Q2 2021
- Shares held
- 45.2M
- +2.15M (+5.0%) vs. Q2 2021
- Total value
- $951.2M
- +$101.5M (+12.0%) vs. Q2 2021
- New holders
- 26
- 44 more added
- Sold out
- 12
- 25 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NGM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 75 | $55.1M |
| Q4 2023 | 83 | $35.3M |
| Q3 2023 | 95 | $50.6M |
| Q2 2023 | 106 | $124.4M |
| Q1 2023 | 123 | $200.4M |
| Q4 2022 | 125 | $248.9M |
| Q3 2022 | 128 | $689.9M |
| Q2 2022 | 124 | $607.3M |
| Q1 2022 | 114 | $732.8M |
| Q4 2021 | 119 | $833.5M |
| Q3 2021 | 121 | $951.2M |
| Q2 2021 | 107 | $849.7M |
| Q1 2021 | 108 | $1.25B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding NGM Biopharmaceuticals Inc; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Price T Rowe Associates Inc | 384,716 | $8.09M | 0.00% | −49,142−11.3% | Reduced |
| AXA S.A. | 405,367 | $8.52M | 0.02% | +112,926+38.6% | Added |
| Jacobs Levy Equity Management, Inc | 457,946 | $9.63M | 0.06% | +205,123+81.1% | Added |
| Boxer Capital, LLC | 500,000 | $10.5M | 0.37% | 00.0% | Unchanged |
| Candriam Luxembourg S.C.A. | 564,059 | $11.9M | 0.08% | 00.0% | Unchanged |
| State Street Corp | 621,163 | $13.1M | 0.00% | +26,545+4.5% | Added |
| JPMorgan Chase & Co | 627,118 | $13.2M | 0.00% | +14,245+2.3% | Added |
| Geode Capital Management, LLC | 643,873 | $13.5M | 0.00% | +68,077+11.8% | Added |
| Citadel Advisors LLC | 758,655 | $15.9M | 0.02% | +50,576+7.1% | Added |
| Euclidean Capital LLC | 832,274 | $17.5M | 8.50% | −661,075−44.3% | Reduced |
| BVF Inc | 955,000 | $20.1M | 0.78% | 00.0% | Unchanged |
| Ponoi Management, LLC | 1,298,908 | $27.3M | 24.24% | 00.0% | Unchanged |
| Ponoi II Management, LLC | 1,298,908 | $27.3M | 40.46% | 00.0% | Unchanged |
| FMR LLC | 1,307,937 | $27.5M | 0.00% | +1,307,937 | New |
| Point72 Asset Management, L.P. | 1,442,994 | $30.3M | 0.14% | +578,794+67.0% | Added |
| Vanguard Group Inc | 1,560,125 | $32.8M | 0.00% | +171,051+12.3% | Added |
| StepStone Group LP | 1,573,357 | $33.1M | 2.14% | +1,573,357 | New |
| BlackRock Inc. | 2,444,832 | $51.4M | 0.00% | +145,477+6.3% | Added |
| Redmile Group, LLC | 2,505,118 | $52.7M | 0.92% | −287,330−10.3% | Reduced |
| Rho Capital Partners Inc | 3,766,666 | $79.2M | 44.14% | 00.0% | Unchanged |
| The Column Group LLC | 15,396,116 | $323.6M | 36.81% | 00.0% | Unchanged |
| Greenspring Associates, LLC | 0 | $0 | 0.00% | −1,573,357−100.0% | Sold out |
| Aquilo Capital Management, LLC | 0 | $0 | 0.00% | −1,194,237−100.0% | Sold out |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −143,567−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −97,313−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −45,739−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −31,200−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −30,253−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −19,551−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −17,550−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −14,047−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −4,305−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |